Over the past quarter, clients have been coming to us with specific volumes and timelines — some are already asking about locking in 2027 supply agreements.
So here's a quick reintroduction to Gadobutrol API from Longzen:
1.About Gadobutrol:
- MRI contrast agent API
- CAS: 198637-52-4
- CEP / CN-DMF / K-DMF / RU-DMF / India Registration
- Commercial-scale GMP production
2.Also from Longzen on the same campus:
- Gadoterate Meglumine (China-DMF Q1 2027)
- Alpha Lipoic Acid / R-ALA (FDA DMF, CEP)
- Teneligliptin Hydrobromide Hydrate
- Mirogabalin Besylate
3.About Longzen:
40-acre campus, 95,000+ m² GMP facilities. Supplying pharmaceutical markets across US, EU, MENA and Asia.
Contact: sales@longzenpharma.com
